Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piret Viiklepp

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|September 15, 2016
Treatment Outcomes in Multidrug-Resistant TuberculosisGunar Günther, Christoph Lange, Sofia Alexandru, et al.
The European Respiratory Journal|June 10, 2017
Treatment outcomes of MDR-TB and HIV co-infection in EuropeCecile Magis-Escurra, Gunar Günther, Christoph Lange, et al.
Emerging Infectious Diseases|February 20, 2015
Multidrug-resistant tuberculosis in Europe, 2010-2011Gunar Günther, Frank van Leth, Sofia Alexandru, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2016
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data MetaanalysisGregory J Fox, Carole D Mitnick, Andrea Benedetti, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|September 15, 2016
Treatment Outcomes in Multidrug-Resistant TuberculosisGunar Günther, Christoph Lange, Sofia Alexandru, et al.
The European Respiratory Journal|June 10, 2017
Treatment outcomes of MDR-TB and HIV co-infection in EuropeCecile Magis-Escurra, Gunar Günther, Christoph Lange, et al.
Emerging Infectious Diseases|February 20, 2015
Multidrug-resistant tuberculosis in Europe, 2010-2011Gunar Günther, Frank van Leth, Sofia Alexandru, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2016
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data MetaanalysisGregory J Fox, Carole D Mitnick, Andrea Benedetti, et al.
Pageof 4